Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:42 AM
Study NCT ID:
NCT01901302
Status:
TERMINATED
Last Update Posted:
2018-11-15
First Post:
2013-07-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-09
First Submit QC Date:
None
Study First Post Date:
2013-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-19
Results First Submit QC Date:
None
Results First Post Date:
2015-07-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-17
Last Update Post Date:
2018-11-15
Last Update Post Date Type:
ACTUAL